Rheumatoid Arthritis Ra clinical trials

Explore recruiting rheumatoid arthritis ra clinical trials.

Recruiting rheumatoid arthritis ra studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rheumatoid Arthritis Ra trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase IIa Proof-of-Concept Study, with Dose-Titration Based on Treat-to-Target Strategy, to Investigate the Efficacy, Safety, and Tolerability of Subcutaneous Injection of Folate-based Liposomes Encapsulating Methotrexate (FBL-MTX) in Disease-modifying Antirheumatic Drugs (DMARD)-naïve Patients with Moderate-to-Severe Active Rheumatoid Arthritis and in Patients with an Inadequate Response or Intolerance to Oral MTX.

Portugal

Therapeutic exploratory (Phase II) EU CTIS Study details

The 3TR Molecular PAthobiology and PRecision Therapy iN EaRly Rheumatoid Arthritis Study

Portugal, Netherlands, Italy, Spain, Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Combination of baricitinib and anti-TNF vs. baricitinib alone in patients with rheumatoid arthritis: a randomized placebo-controlled phase-III trial - CRI-RA

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Randomized placebo-controlled trial comparing Methotrexate vs. Methotrexate/Metformin association in rheumatoid arthritis patients: METorMET² study.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA)

Germany, Italy, Poland

Human Pharmacology (Phase I)- Other EU CTIS Study details

A MULTICENTER, PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF SPIRONOLACTONE FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS (RA) - ALDORA

Germany, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Rheumatoid Arthritis Ra trials by city

Rheumatoid Arthritis Ra in Toronto Rheumatoid Arthritis Ra in Vancouver Rheumatoid Arthritis Ra in Montreal Rheumatoid Arthritis Ra in Calgary Rheumatoid Arthritis Ra in Edmonton Rheumatoid Arthritis Ra in Ottawa Rheumatoid Arthritis Ra in Winnipeg Rheumatoid Arthritis Ra in Quebec City Rheumatoid Arthritis Ra in Hamilton Rheumatoid Arthritis Ra in Kitchener Rheumatoid Arthritis Ra in London Rheumatoid Arthritis Ra in Halifax Rheumatoid Arthritis Ra in New York Rheumatoid Arthritis Ra in Los Angeles Rheumatoid Arthritis Ra in Chicago Rheumatoid Arthritis Ra in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease